Human Mobility and Droplet-Transmissible Pediatric Infectious Diseases during the COVID-19 Pandemic.
coronavirus disease-2019
droplet infectious disease
human mobility
movement of people
pandemic
pediatric infectious disease
social distancing
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
06 06 2022
06 06 2022
Historique:
received:
18
04
2022
revised:
01
06
2022
accepted:
04
06
2022
entrez:
10
6
2022
pubmed:
11
6
2022
medline:
14
6
2022
Statut:
epublish
Résumé
The study tested the hypothesis that human mobility may be a potential factor affecting reductions in droplet-transmissible pediatric infectious diseases (PIDs) during the coronavirus disease-2019 (COVID-19) pandemic mitigation period in 2020. An ecological study was conducted using two publicly available datasets: surveillance on infectious diseases collected by the Japanese government and COVID-19 community mobility reports presented by Google. The COVID-19 community mobility reports demonstrated percentage reductions in the movement of people over time in groceries and pharmacies, parks, and transit stations. We compared the weekly trends in the number of patients with droplet-transmissible PIDs identified in 2020 with those identified in the previous years (2015-2019) and assessed the correlations between the numbers of patients and percentage decreases in human mobility during 2020. Despite experiencing their peak seasons, dramatic reductions were found in the numbers of patients with pharyngoconjunctival fever (PCF) and group A streptococcal (GAS) pharyngitis after the tenth week of 2020. Beyond the 20th week, no seasonal peaks were observed in the number of patients with all PIDs identified in 2020. Significant correlations were found between the percentage decreases in human mobility in transit stations and the number of patients with hand-foot-and-mouth disease (Pearson correlation coefficient [95% confidence interval]: 0.65 [0.44-0.79]), PCF (0.47 [0.21-0.67]), respiratory syncytial virus infection (0.45 [0.19-0.66]), and GAS pharyngitis (0.34 [0.06-0.58]). The highest correlations were found in places underlying potential human-to-human contacts among adults. These findings suggest that reductions in human mobility for adults might contribute to decreases in the number of children with droplet-transmissible PIDs by the potential prevention of adult-to-child transmission.
Identifiants
pubmed: 35682525
pii: ijerph19116941
doi: 10.3390/ijerph19116941
pmc: PMC9180602
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
BMC Infect Dis. 2020 Nov 19;20(1):859
pubmed: 33213360
Clin Infect Dis. 2021 Feb 16;72(4):598-603
pubmed: 32594121
Clin Infect Dis. 2021 Dec 16;73(12):2265-2275
pubmed: 33460434
Epidemiol Infect. 2020 Oct 08;148:e249
pubmed: 33028445
Epidemiol Infect. 2020 Nov 13;148:e282
pubmed: 33183397
BMC Pediatr. 2020 Dec 23;20(1):562
pubmed: 33353540
JAMA. 2020 Dec 1;324(21):2155-2156
pubmed: 33185657
Eur J Pediatr. 2021 Jun;180(6):1955-1963
pubmed: 33555426
Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S138-45
pubmed: 21342886
Pediatrics. 2011 Apr;127(4):e898-904
pubmed: 21422083
Eur J Pediatr. 2021 Jun;180(6):1991-1995
pubmed: 33502627
Pediatrics. 2020 Oct;146(4):
pubmed: 32879032
Clin Infect Dis. 2010 Jan 15;50(2):165-74
pubmed: 20021259
N Engl J Med. 1976 Feb 19;294(8):414-9
pubmed: 173995
Am J Emerg Med. 2021 May;43:115-117
pubmed: 33556796
Eur J Pediatr. 2021 May;180(5):1497-1504
pubmed: 33409588
Eur J Pediatr. 2008 Apr;167(4):395-9
pubmed: 17541638
Open Forum Infect Dis. 2015 Jan 03;2(1):ofu118
pubmed: 25884006
J Infect Dis. 2014 Jun 1;209(11):1685-92
pubmed: 24367040
BMC Infect Dis. 2021 Jan 12;21(1):58
pubmed: 33435892
Infect Dis Model. 2020 Apr 21;5:293-308
pubmed: 32355904
Lancet Infect Dis. 2020 Nov;20(11):1247-1254
pubmed: 32621869
Pediatr Infect Dis J. 2020 Sep;39(9):e221-e225
pubmed: 32639459
Pediatr Infect Dis J. 2020 Dec;39(12):e423-e427
pubmed: 32773660
Clin Infect Dis. 2021 Jan 27;72(2):319-322
pubmed: 33501967
J Hosp Infect. 2020 Nov;106(3):610-612
pubmed: 32781200
Infect Dis (Lond). 2021 May;53(5):376-381
pubmed: 33512254
Eur J Pediatr. 2021 Jun;180(6):1969-1973
pubmed: 33517482
Epidemiol Infect. 2021 Jan 14;149:e24
pubmed: 33441205
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):707-711
pubmed: 32426062